Massachusetts General Hospital
National Cancer Institute (NCI)
Investigators use a genome-wide approach within a case-control design to identify SNPs that show evidence of association with lung cancer risk and survival.
|Ages eligible for Study||18 Years and older|
|Genders eligible for Study||All|
|Accepts Healthy Volunteers||Accepts Healthy Volunteers|
- healthy controls: participants without evidence of any cancer
- cases: pathology proven primary lung cancer
- younger than 18 years old
Investigators also investigate how genetic variants may affect cancer treatment, at various stages of disease development, in order to determine prognostic and predictive factors for survival.
United States (1)
- Massachusetts General HospitalrecruitingBoston, Massachusetts, United States, 02114
31 May, 1993
30 August, 2017